Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 144 Cr.
- Current Price ₹ 138
- High / Low ₹ 260 / 121
- Stock P/E 18.8
- Book Value ₹ 46.8
- Dividend Yield 0.00 %
- ROCE 45.0 %
- ROE 41.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 52.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.0%
- Company's working capital requirements have reduced from 27.4 days to 14.7 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 46.7 to 57.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
51 | 56 | 56 | 60 | 101 | 109 | |
48 | 53 | 53 | 57 | 95 | 98 | |
Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 |
OPM % | 5% | 5% | 5% | 5% | 6% | 10% |
0 | 0 | 0 | 1 | 2 | 2 | |
Interest | 1 | 1 | 2 | 2 | 2 | 2 |
Depreciation | 0 | 1 | 0 | 1 | 1 | 1 |
Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 |
Tax % | 10% | 8% | 41% | 9% | 25% | 24% |
1 | 1 | 0 | 1 | 5 | 8 | |
EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 413.07 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 25% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 52% |
3 Years: | 148% |
TTM: | 66% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | 35% |
Last Year: | 42% |
Balance Sheet
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|
Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 |
Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 38 |
9 | 11 | 14 | 14 | 10 | 7 | 7 | |
12 | 14 | 23 | 15 | 32 | 34 | 34 | |
Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 90 |
7 | 8 | 10 | 11 | 12 | 13 | 17 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
21 | 25 | 33 | 29 | 42 | 51 | 73 | |
Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 90 |
Cash Flows
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
0 | 0 | 2 | -4 | 12 | 9 | |
0 | 0 | -2 | -2 | -0 | -2 | |
0 | 0 | 2 | 5 | -8 | -4 | |
Net Cash Flow | 0 | 0 | 2 | -2 | 4 | 3 |
Ratios
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 |
Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 |
Days Payable | 102 | 97 | 143 | 89 | 92 | 110 |
Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 |
Working Capital Days | 12 | 23 | 14 | 66 | 2 | 15 |
ROCE % | 15% | 12% | 14% | 32% | 45% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 10h
- Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024 12 Apr
- Compliance Certificate Issued Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended 31St March, 2024 12 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Apr - Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2024.
- Closure of Trading Window 28 Mar
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions